2025 AHA CME Symposium – Exploring the Evidence: GLP-1 RA in Individuals with T2D and ASCVD

2025 AHA CME Symposium

Hazlet, NJ , October 9, 2025 , prlog – In this symposium, an expert faculty will discuss data from injectable GLP-1 RA in ASCVD patients and the place of injectable GLP-1 RA in reducing cardiovascular risk. The design, efficacy and safety results from the SOUL trial will be presented, as well as the latest meta-analyses with GLP-1 RAs. Cases from patients with T2D and ASCVD will be presented, and attendees will be provided with best practices incorporating evidence-based clinical decision making and patient-centered care.

Click here for more information (https://symposiareg.com/22510/)

Chair

Darren McGuire, MD MHSC
Distinguished Chair in Cardiology
Distinguished Teaching Professor
University of Texas Southwestern Medical Center
Dallas, Texas

faculty

Lawrence Leiter, MD, FRCPC
Professor of Medicine and Nutrition Sciences
University of Toronto
Toronto, Ontario, Canada

Neha Believes, MD, MPH
Associate Professor of Medicine
Duke University School of Medicine
Durham, North Carolina

Richard Pratley, MD
Samuel E. Crockett Chair in Diabetes Research
AdventHealth Translational Research Institute
Medical Director, AdventHealth Diabetes Institute
Orlando Florida

educational purposes
– Describe pivotal injectable GLP-1 RA clinical trials and meta analyzes in patients with T2D and high ASCVD risk
– Explain the American Diabetes Association 2025 guideline recommendations for the use of GLP-1 RA in patients with T2D and ASCVD or multiple risk factors for ASCVD.
– Interpret evidence from the SOUL trial and describe the potential role of oral GLP-1 RA therapy in T2D and high-risk patients

target audience
This program is for cardiologists and other health care professionals who manage patients with T2D and ASCVD risk.

educational grant
Voxmedia International gratefully acknowledges an educational grant from Novo Nordisk Inc.

Accreditation and Credit Designation Details
Voxmedia, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia, LLC designates this live activity for maximum 1.5 AMA PRA Category CreditPractitioners should claim credit commensurate with the extent of their participation in the activity. Nurse practitioners can participate in this educational activity and earn a certificate of completion if accepted by the AANP AMA PRA Category 1 Credit Through their mutual agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit From ACCME accredited organizations.